Skip to main content

Table 2 Comparison of the survival rates for ICRT VS ICCCRT

From: Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study

Variable

ICRT arm

ICCCRT arm

OS (%)

 At 3-years

79.1

86.1

 At 5-years

57.5

47.8

PFS (%)

 At 3-years

64.7

80.5

 At 5-years

41.8

38.4

  1. ICRT induction chemotherapy plus radiotherapy, ICCCRT concurrent chemotherapy plus radiotherapy